Search

everythinglearnresearchcommunity

for

Search:↓

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.